Aspen Seeks Drugs Acquisitions as Overseas Deals Fuel GrowthBy
South African group looks to expand infant nutrition overseas
Shares gain most in almost four months in Johannesburg trading
Aspen Pharmacare Holdings Ltd., Africa’s largest generic-drugs maker, is looking for acquisitions and seeking to expand its infant nutrition business after international sales boosted full-year profit.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.